According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), Corvus Pharmaceuticals, Inc. has signed a revised equity distribution agreement.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pi Network: Will mainnet KYC upgrades save PI crypto from drop to $0.076?
Why Is Tether Bringing USDT Back to Bitcoin Now? Morgan Stanley Offers a Clue
Swiss Franc: Dovish SNB keeps CHF under pressure against US Dollar – ING
Japan Central Bank inflation indicators accelerate, providing grounds for further interest rate hikes
An indicator used by the Bank of Japan to measure underlying inflation accelerated last month, significantly exceeding its target level, providing further justification for continuing to raise the benchmark interest rate.
Crypto prices
More
